Avricore Health Inc.
Loading stock data...
Stock Performance
Price History
-
Drag to select time range
-
Market Data
Market Cap
7.6M
P/E Ratio
-
52-Week High
-
52-Week Low
-
Avg Volume
-
Beta
-
Forward P/E
-
Dividend Yield
-
EV/Revenue
-
Price/Book
-
Business Overview
Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
Healthcare
Diagnostics & Research
TSXV
Key Financial Metrics
4.8M
Revenue
-668,977
Net Income
C$-0.01
EPS (Diluted)
799,268
Free Cash Flow
Profitability
Gross Margin
39.3%
Operating Margin
2.9%
Net Profit Margin
-14.0%
EBITDA
589,544
Returns & Efficiency
Return on Assets (ROA)
-29.1%
Return on Equity (ROE)
-34.0%
Dividend Yield
-
Payout Ratio
-
Financial Health
Total Assets
2.3M
Total Debt
-
Debt to Equity
-
Current Ratio
4.78
Company Info
| Industry | Diagnostics & Research |
| HQ | Vancouver, Canada |
| Fiscal Year End | 1735603200 |
| Currency | CAD |
| Website | avricore.com |
Peers
Bausch + Lomb Corporation
BLCO.TO
7.9B
P/E: --
Bausch Health Companies Inc.
BHC.TO
2.5B
P/E: 12.0
Extendicare Inc.
EXE.TO
2.5B
P/E: 23.7
Sienna Senior Living Inc.
SIA.TO
2.2B
P/E: 53.2
Cronos Group Inc.
CRON.TO
1.4B
P/E: 24.1
Tilray Brands, Inc.
TLRY.TO
1.2B
P/E: --
WELL Health Technologies Corp.
WELL.TO
1.1B
P/E: --
Knight Therapeutics Inc.
GUD.TO
631.8M
P/E: --
Insider Activity
Sentiment
Bullish
Shares Bought
30,000
Shares Sold
0
Total Transactions
1
SEDAR+ Filings
View All Filings3
Annual Reports
22
Quarterly Reports
28
MD&A
103
News Releases
16
Material Changes
13
Governance
56
Certifications
30
Other
●
29 Apr 2024
●
2024-04-29
●
2020-04-29
Interactive Charts
Company Profile
General Information
| Company Name | Avricore Health Inc. |
| Ticker | AVCR.V |
| Exchange | TSXV |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Headquarters | Vancouver, Canada |
| Fiscal Year End | 1735603200 |
| Currency | CAD |
| Website | avricore.com |
Financial Summary
| Market Cap | 7.6M |
| Revenue | 4.8M |
| Net Income | -668,977 |
| P/E Ratio | N/A |
| EPS (Diluted) | C$-0.01 |
| Net Margin | -14.0% |
| ROE | -34.0% |
| Dividend Yield | N/A |
Business Description
Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.